Extent of Drug Patents With Terminal Disclaimers and Obviousness-Type Double Patenting Rejections - O'Neill : O'Neill

National Library of Medicine | September 10, 2024

Read the Publication

Latest publications See All

Journal Article

September 16, 2025

Excess HIV Infections and Costs Associated With Reductions in HIV Prevention Services in the US

Op-Ed

September 16, 2025

Unpacking The Supreme Court’s Decision Over NIH Funding

September 8, 2025

State Action to Lower Prescription Drug Prices: Navigating the Dormant Commerce Clause